BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 Million

BioPharmaX (NYSEMKT:BOMX) announced the pricing of an underwritten public offering of 3,600,000 shares of common stock and warrants to purchase 1,800,000 shares of common stock with a public offering price of $1.20 for one share common stock and a warrant to purchase 0.5 of a share of common stock.
According to the news:

The company expects to receive gross proceeds of approximately $4.3 million, before deducting underwriting discounts and commissions and other estimated offering expenses. The company has also granted the underwriters a 45 day option to purchase up to an additional 324,000 shares of common stock and/or warrants to purchase up to an additional 162,000 shares of common stock to cover over-allotments, if any.